Target intelligence / Profile preview

Immunoglobulin heavy variable 3-38 (IGHV3-38)

Target
IGHV3-38
Molecular classification
Immunoglobulin gene segment, Variable region of antibody heavy chain, Pseudogene/open reading frame (non-functional), Other
01

Overview

Immunoglobulin heavy variable 3-38 (IGHV3-38) is a gene segment within the immunoglobulin heavy chain locus (IGH) on chromosome 14q32.33, involved in encoding the variable domain of immunoglobulin heavy chains[2][3]. IGHV3-38 is classified as a probable non-functional open reading frame (ORF), meaning it does not contribute to the synthesis of productive immunoglobulin chains due to alterations in its recombination, splicing sites, or protein sequence[3][4]. While variable immunoglobulin heavy chain genes are critical for the antigen-binding diversity of antibodies and thus the adaptive immune system, IGHV3-38 itself does not encode a functional antibody or receptor and is not a therapeutic target, receptor, enzyme, or druggable entity[3][4]. IGHV gene segments are highly polymorphic, often subject to copy number variants and population-specific structural variation[2][5]. The non-functional nature of IGHV3-38 precludes its involvement as a biomarker or direct disease modifier; instead, the gene is categorized among numerous pseudogenic or altered IGHV loci that collectively contribute to immunoglobulin locus genetic complexity[2][3][4][5].

Other names
IGHV338HV338 proteinProbable non-functional immunoglobulin heavy variable 3-38Immunoglobulin heavy chain variable regionimmunoglobulin heavy variable 3-38 (non-functional)
02

Mechanism of action

Not applicable (IGHV3-38 is not a functional protein and is not a drug target)

03

Biological functions

None demonstrated directly for IGHV3-38 (non-functional)Antigen binding (through variable domain)Humoral immune response initiation
04

Disease associations

None demonstrated for IGHV3-38 (non-functional)Variations in IGHV repertoire can impact susceptibility to infection, autoimmunity, and therapeutic antibody responsesRole in antibody diversity generation (general, not specific to this allele)
05

Safety considerations

None specific.In general, genetic variability in IGHV loci can affect antibody responses and efficacy of antibody-based therapies in population genetics, but IGHV3-38 itself is not therapeutically actionable.
06

Biomarkers

None documented for IGHV3-38 specifically.IGHV polymorphisms are studied as genetic biomarkers for immune repertoire diversity.

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-38 (IGHV3-38).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-38 (IGHV3-38).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call